Miniao, Jelyn C.

HRN: 26-06-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/27/2025
08/03/2025
IV
550mg
Q 6 Hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines